Literature DB >> 16695957

Quantitative immunology of immune hemolytic anemia: II. The relationship of cell-bound antibody to hemolysis and the effect of treatment.

W F Rosse1.   

Abstract

The concentration of cell-bound and serum antibody was determined in a series of patients with warm antibody immune hemolytic anemia by determining the amount of C[unk]1 fixed to the cells by anti-IgG. This was compared to the rate of hemolysis as determined by hemoglobin concentration and reticulocyte count, or the endogenous production of carbon monoxide. The rate of hemolysis was, in general, proportional to the concentration of cell-bound antibody. In splenectomized patients, the rate of hemolysis was very much less than in unsplenectomized patients for a given concentration of cell-bound antibody. When prednisone was given, three effects were noted: (a) at high doses of drug, the concentration of cell-bound antibody decreased rapidly and the concentration of serum antibody increased, suggesting that the affinity of antibody for antigen had been altered; (b) in patients achieving remission, the concentration of serum antibody fell to low levels but rose again if the dose of prednisone was insufficient; (c) in one patient, prednisone appeared to inhibit sequestration of highly sensitized cells.

Entities:  

Year:  1971        PMID: 16695957      PMCID: PMC291987          DOI: 10.1172/JCI106544

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  QUANTITATIVE STUDIES OF THE EFFECT OF RED-BLOOD-CELL SENSITIZATION ON IN VIVO HEMOLYSIS.

Authors:  M CONSTANTOULAKIS; N COSTEA; R S SCHWARTZ; W DAMESHEK
Journal:  J Clin Invest       Date:  1963-11       Impact factor: 14.808

2.  EFFECTS OF LOW IONIC STRENGTH ON IMMUNE HEMOLYSIS.

Authors:  H J RAPP; T BORSOS
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

3.  AN EVALUATION OF DFP AND CR AS METHODS OF MEASURING RED CELL LIFE SPAN IN MAN.

Authors:  M J CLINE; N I BERLIN
Journal:  Blood       Date:  1963-10       Impact factor: 22.113

4.  RATE OF REMOVAL FROM THE CIRCULATION OF RED CELLS SENSITIZED WITH DIFFERENT AMOUNTS OF ANTIBODY.

Authors:  P L MOLLISON; P CROME; N C HUGHES-JONES; E ROCHNA
Journal:  Br J Haematol       Date:  1965-07       Impact factor: 6.998

5.  Autoimmune hemolytic disease. Antibody dissociation and activity.

Authors:  R S EVANS; M BINGHAM; P BOEHNI
Journal:  Arch Intern Med       Date:  1961-09

6.  The erythrocyte-coating substance in autoimmune hemolytic disease: its nature and significance.

Authors:  H FUDENBERG; I BARRY; W DAMESHEK
Journal:  Blood       Date:  1958-03       Impact factor: 22.113

7.  Immunohematological studies in hemolytic anemia.

Authors:  I DAVIDSOHN
Journal:  J Am Med Assoc       Date:  1954-03-06

8.  Complement fixation on cell surfaces by 19S and 7S antibodies.

Authors:  T Borsos; H J Rapp
Journal:  Science       Date:  1965-10-22       Impact factor: 47.728

9.  Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.

Authors:  I Gigli; R A Nelson
Journal:  Exp Cell Res       Date:  1968-07       Impact factor: 3.905

10.  Endogenous carbon monoxide production in patients with hemolytic anemia.

Authors:  R F Coburn; W J Williams; S B Kahn
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

View more
  12 in total

1.  Quantitative influence of antibody and complement coating of red cells on monocyte-mediated cell lysis.

Authors:  R J Kurlander; W F Rosse; G L Logue
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Pathogenesis of hemolysis in immune hemolytic anemia.

Authors:  J R Cohen
Journal:  West J Med       Date:  1977-10

3.  Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes.

Authors:  J P Atkinson; A D Schreiber; M M Frank
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

4.  Small quantities of erythrocyte bound immunoglobulins and autoimmune haemolysis.

Authors:  R J Sokol; S Hewitt; D J Booker; R Stamps
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

5.  Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D).

Authors:  A Salama; V Kiefel; R Amberg; C Mueller-Eckhardt
Journal:  Blut       Date:  1984-07

6.  Quantitative immunology of immune hemolytic anemia. I. The fixation of C1 by autoimmune antibody and heterologous anti-IgG antibody.

Authors:  W F Rosse
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

7.  Therapeutic treatment of New Zealand mouse disease by a limited number of anti-idiotypic antibodies conjugated with neocarzinostatin.

Authors:  N Harata; T Sasaki; H Osaki; T Saito; S Shibata; T Muryoi; O Takai; K Yoshinaga
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

8.  Effect of corticosteroids on the human monocyte IgG and complement receptors.

Authors:  A D Schreiber; J Parsons; P McDermott; R A Cooper
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

9.  Anticapsular antibody requirements for protection against experimental Haemophilus influenzae type b bacteremia after splenectomy.

Authors:  L G Rubin
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

10.  Lipid peroxidation of erythrocytes during anemia of the hamsters infected with Leishmania donovani.

Authors:  T Biswas; J K Pal; K Naskar; D K Ghosh; J Ghosal
Journal:  Mol Cell Biochem       Date:  1995-05-24       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.